Algernon Pharmaceuticals Inc (AGNPF)

[markna]

AMG, don’t you think investors are waiting to see if the company can raise the money fund its studies? Can’t do studies without money. They can keep press releasing animal data and advisors, but does it matter without having the $ to do clinical studies . I don’t mean to keep bringing this up but starting to look concerning after they could only raise half a million last fall on the “new direction”. What happens if they can’t raise the money in coming weeks?